38 related articles for article (PubMed ID: 28916441)
1. Antidepressant-like deliverables from the sea: evidence on the efficacy of three different brown seaweeds via involvement of monoaminergic system.
Siddiqui PJA; Khan A; Uddin N; Khaliq S; Rasheed M; Nawaz S; Hanif M; Dar A
Biosci Biotechnol Biochem; 2017 Jul; 81(7):1369-1378. PubMed ID: 28406051
[TBL] [Abstract][Full Text] [Related]
2. Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in mice.
Deyama S; Li XY; Duman RS
Neuropsychopharmacol Rep; 2024 Mar; 44(1):246-249. PubMed ID: 37960997
[TBL] [Abstract][Full Text] [Related]
3. Investigation of mechanisms of action involved in the antidepressant-like effect of Trans,trans-farnesol in mice.
Delmondes GA; Pereira Lopes MJ; Borges AS; Bezerra DS; Silva JPD; Souto BS; Costa JGDS; Campos PES; Santana TI; Coutinho HDM; Barbosa-Filho JM; Alencar de Menezes IR; Bezerra Felipe CF; Kerntopf MR
Chem Biol Interact; 2023 Dec; 386():110791. PubMed ID: 37923004
[TBL] [Abstract][Full Text] [Related]
4. Metabolite profiling of antidepressant drug action reveals novel drug targets beyond monoamine elevation.
Webhofer C; Gormanns P; Tolstikov V; Zieglgänsberger W; Sillaber I; Holsboer F; Turck CW
Transl Psychiatry; 2011 Dec; 1(12):e58. PubMed ID: 22832350
[TBL] [Abstract][Full Text] [Related]
5. Development of Two Green and High Throughput Microwell Spectrometric Platforms for Determination of Reboxetine, the First FDA-Approved Selective Noradrenaline Reuptake Inhibitor Antidepressant Drug.
Darwish IA; Alsalhi MS
J AOAC Int; 2024 Jun; ():. PubMed ID: 38941495
[TBL] [Abstract][Full Text] [Related]
6. Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.
Ren Z; Yan P; Zhu L; Yang H; Zhao Y; Kirby BP; Waddington JL; Zhen X
Psychopharmacology (Berl); 2018 Jan; 235(1):233-244. PubMed ID: 29058041
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of gallic acid in mice: Dual involvement of serotonergic and catecholaminergic systems.
Can ÖD; Turan N; Demir Özkay Ü; Öztürk Y
Life Sci; 2017 Dec; 190():110-117. PubMed ID: 28942286
[TBL] [Abstract][Full Text] [Related]
8. Glial Purinergic Signaling-Mediated Oxidative Stress (GPOS) in Neuropsychiatric Disorders.
Huang L; Tang Y; Sperlagh B
Oxid Med Cell Longev; 2022; 2022():1075440. PubMed ID: 35281471
[TBL] [Abstract][Full Text] [Related]
9. Massive efflux of adenosine triphosphate into the extracellular space immediately after experimental traumatic brain injury.
Moro N; Ghavim SS; Sutton RL
Exp Ther Med; 2021 Jun; 21(6):575. PubMed ID: 33850547
[TBL] [Abstract][Full Text] [Related]
10. Purinergic Signaling and Related Biomarkers in Depression.
Bartoli F; Burnstock G; Crocamo C; Carrà G
Brain Sci; 2020 Mar; 10(3):. PubMed ID: 32178222
[TBL] [Abstract][Full Text] [Related]
11. Reduced P2X receptor levels are associated with antidepressant effect in the learned helplessness model.
Ribeiro DE; Casarotto PC; Staquini L; Pinto E Silva MA; Biojone C; Wegener G; Joca S
PeerJ; 2019; 7():e7834. PubMed ID: 31656696
[TBL] [Abstract][Full Text] [Related]
12. P2X7 Receptor Signaling in Stress and Depression.
Ribeiro DE; Roncalho AL; Glaser T; Ulrich H; Wegener G; Joca S
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174279
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels.
Sales AJ; Crestani CC; Guimarães FS; Joca SRL
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():255-261. PubMed ID: 29885468
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant-like effect of the hydroethanolic leaf extract of Alchornea cordifolia (Schumach. & Thonn.) Mull. Arg. (Euphorbiaceae) in mice: involvement of monoaminergic system.
Ishola IO; Agbaje EO; Akinleye MO; Ibeh CO; Adeyemi OO
J Ethnopharmacol; 2014 Dec; 158 Pt A():364-72. PubMed ID: 25448506
[TBL] [Abstract][Full Text] [Related]
15. Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs.
Stein AC; Viana AF; Müller LG; Nunes JM; Stolz ED; Do Rego JC; Costentin J; von Poser GL; Rates SM
Behav Brain Res; 2012 Mar; 228(1):66-73. PubMed ID: 22155486
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?
Adell A
Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):113-21. PubMed ID: 15078186
[TBL] [Abstract][Full Text] [Related]
17. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
Quesseveur G; Gardier AM; Guiard BP
Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
[TBL] [Abstract][Full Text] [Related]
18. Monoamine involvement in the antidepressant-like effect induced by P2 blockade.
Diniz CRAF; Rodrigues M; Casarotto PC; Pereira VS; Crestani CC; Joca SRL
Brain Res; 2017 Dec; 1676():19-27. PubMed ID: 28916441
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
